Literature DB >> 33004356

First do no harm: valproate and medicines safety in pregnancy.

John Robson1, Ngawai Moss1, Patricia McGettigan2, Samantha Jane Beardsley1, Elizabeth Lovegrove1, Carol Dezateux1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33004356      PMCID： PMC7518898          DOI： 10.3399/bjgp20X712673

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  7 in total

1.  Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.

Authors:  Torbjörn Tomson; Dina Battino; Erminio Bonizzoni; John Craig; Dick Lindhout; Emilio Perucca; Anne Sabers; Sanjeev V Thomas; Frank Vajda
Journal:  Lancet Neurol       Date:  2018-04-18       Impact factor: 44.182

2.  Major congenital malformations after first-trimester exposure to ACE inhibitors.

Authors:  William O Cooper; Sonia Hernandez-Diaz; Patrick G Arbogast; Judith A Dudley; Shannon Dyer; Patricia S Gideon; Kathi Hall; Wayne A Ray
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

3.  Pregnancy protection and pregnancies in women prescribed ACE inhibitors or ARBs: a cross-sectional study in primary care.

Authors:  Elizabeth Lovegrove; John Robson; Patricia McGettigan
Journal:  Br J Gen Pract       Date:  2020-10-29       Impact factor: 5.386

4.  AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies.

Authors:  Shakila Thangaratinam; Nadine Marlin; Sian Newton; Annalise Weckesser; Manny Bagary; Lynette Greenhill; Rachel Rikunenko; Maria D'Amico; Ewelina Rogozińska; Andrew Kelso; Kelly Hard; Jamie Coleman; Ngawai Moss; Tracy Roberts; Lee Middleton; Julie Dodds; Angela Pullen; Sandra Eldridge; Alexander Pirie; Elaine Denny; Doug McCorry; Khalid S Khan
Journal:  Health Technol Assess       Date:  2018-05       Impact factor: 4.014

5.  A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.

Authors:  Carol Paton; John Cookson; I Nicol Ferrier; Sumera Bhatti; Elizabeth Fagan; Thomas R E Barnes
Journal:  BMJ Open       Date:  2018-04-12       Impact factor: 2.692

Review 6.  Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?

Authors:  Alastair Macfarlane; Trisha Greenhalgh
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-01       Impact factor: 3.007

7.  Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study.

Authors:  Pierre-Olivier Blotière; Sara Miranda; Alain Weill; Yann Mikaeloff; Hugo Peyre; Franck Ramus; Zureik Mahmoud; Joël Coste; Rosemary Dray-Spira
Journal:  BMJ Open       Date:  2020-06-07       Impact factor: 3.006
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.